Bank of Jackson Hole Trust Has $110,000 Holdings in Axon Enterprise, Inc $AXON

Bank of Jackson Hole Trust reduced its position in Axon Enterprise, Inc (NASDAQ:AXON) by 44.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 133 shares of the biotechnology company’s stock after selling 105 shares during the period. Bank of Jackson Hole Trust’s holdings in Axon Enterprise were worth $110,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. TCI Wealth Advisors Inc. acquired a new position in Axon Enterprise in the 2nd quarter worth about $214,000. Duncker Streett & Co. Inc. raised its stake in shares of Axon Enterprise by 3.2% in the 2nd quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock valued at $12,006,000 after acquiring an additional 448 shares in the last quarter. Quotient Wealth Partners LLC bought a new position in shares of Axon Enterprise in the 1st quarter valued at approximately $438,000. New York Life Investment Management LLC raised its stake in shares of Axon Enterprise by 3.2% in the 2nd quarter. New York Life Investment Management LLC now owns 11,044 shares of the biotechnology company’s stock valued at $9,144,000 after acquiring an additional 341 shares in the last quarter. Finally, DAVENPORT & Co LLC raised its stake in shares of Axon Enterprise by 5.1% in the 1st quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company’s stock valued at $494,000 after acquiring an additional 46 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

AXON opened at $759.44 on Thursday. The firm has a market capitalization of $59.62 billion, a P/E ratio of 187.52, a price-to-earnings-growth ratio of 29.32 and a beta of 1.41. The stock’s 50 day moving average price is $732.23 and its two-hundred day moving average price is $730.52. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12-month low of $422.38 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s revenue was up 32.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer owned 15,003 shares of the company’s stock, valued at $11,402,280. This represents a 0.51% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 59,932 shares of company stock worth $45,115,616. 4.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on AXON shares. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. JMP Securities reissued a “market outperform” rating and issued a $825.00 price objective on shares of Axon Enterprise in a research note on Monday, September 29th. JPMorgan Chase & Co. raised their price objective on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. UBS Group reissued a “neutral” rating and issued a $840.00 price objective (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.